NCT06536959 2024-08-05VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDSBeijing 302 HospitalPhase 2 Recruiting67 enrolled
NCT04541277 2020-09-09Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive ChemotherapyChinese PLA General HospitalPhase 2 Unknown55 enrolled